Amgen Inc $122.84

up +0.58


25/7/2014 04:00 PM  |  NASDAQ : AMGN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AMGN Trend Analysis - it has underperformed the S&P 500 by 3%

Partner Headlines

  1. US Stock Futures Drop Ahead Of Durable Goods Orders Data

    Benzinga
  2. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  3. UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment ...

    Benzinga
  4. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  5. Morgan Stanley Issues 2015 'Vintage Values' Stock List

    Benzinga
  6. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  7. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  8. Bind Therapeutics

    IBD
  9. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  10. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  11. Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%

    Benzinga
  12. Morning Market Losers

    Benzinga
  13. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  14. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  15. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  16. UPDATE: Morgan Stanley Reiterates On Amgen On New CFO

    Benzinga
  17. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  18. UPDATE: Morgan Stanley Reiterates On Amgen Following AMAGINE-1 Study

    Benzinga
  19. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca ...

    GuruFocus
  20. Amgen

    IBD
  21. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  22. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  23. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces ...

    Benzinga
  24. Stocks End Six-Day Win Streak As Techs Sell Off

    IBD
  25. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  26. #PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure ...

    Benzinga
  27. AMGEN

    IBD
  28. Gilead Soars As Hep C Drug Shatters Views; Amgen Misses

    IBD
  29. Rallying Ahead of Earnings

    FoxBusiness
  30. Nasdaq, S&P 500 On Track For Sixth Straight Gain

    IBD
  31. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  32. Stocks Power Out Early Gains; Allergan Leads Drug-Maker Surge

    IBD
  33. Earnings Scheduled For April 22, 2014

    Benzinga
  34. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  35. Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

    Benzinga
  36. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  37. UPDATE: Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response ...

    Benzinga
  38. Amgen, GSK End Marketing Pact for Osteoporosis Drug

    FoxBusiness
  39. Cholesterol drug meets goal

    IBD
  40. Trial Results Lift Drug Sector

    IBD
  41. Amgen Stock Gets Bump Up On Cholesterol Drug Data

    IBD
  42. Jefferies Raises PT On Amgen, Pricing Pressure Factored IN

    Benzinga
  43. Gilead Adds To Biotech Woes

    IBD
  44. Gilead Sovaldi Scrips Falter As Biotechs Keep Falling

    IBD
  45. New Cholesterol Fighters To Take Center Stage At ACC

    IBD
  46. Market Wrap For March 27: Markets Lower Following Mixed Economic Data

    Benzinga
  47. Biotech ETFs Come Back Down To Earth

    Benzinga
  48. Morgan Stanley's Top Biotech Pick is Biogen

    Benzinga
  49. BIOGEN IDEC

    IBD
  50. Have We Seen The Top Of The Market?

    Benzinga
Trading Center